Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50
Closed -$4K 143
2022
Q3
$4K Sell
50
-121
-71% -$10.8K ﹤0.01% 163
2022
Q2
$16K Hold
171
0.01% 138
2022
Q1
$14K Hold
171
0.01% 136
2021
Q4
$13K Buy
+171
New +$13.6K 0.01% 139

Other funds holding MRK

PYA Waltman Capital's MRK Position: Q4 2022 in Review

PYA Waltman Capital sold out of Merck (MRK) in Q4 2022, closing a stake of 50 shares — an estimated $4K sold.

PYA Waltman Capital first reported a position in MRK in Q4 2021 and held it in 4 quarters. The position peaked at $16K in Q2 2022. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • PYA Waltman Capital reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • PYA Waltman Capital sold 50 Merck shares in Q4 2022, an estimated $4K.
  • PYA Waltman Capital first reported a position in Merck in Q4 2021 and held it in 4 quarters.
  • PYA Waltman Capital's Merck position peaked at $16K in Q2 2022.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on PYA Waltman Capital's 13F filing for Q4 2022, filed 14 Feb 2023.